CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Teva Pharmaceuticals USA, Inc. v. Amneal Pharmaceuticals LLC

1:17-cv-00992

Overview

Case Number 1:17-cv-00992
Filing Date 2017-07-20
Status Terminated
Termination Date 2018-01-02
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

Amneal Pharmaceuticals Co. GmbH Operating Company

Represented By

1 Attorneys Listed

Richard L. Renck

Duane Morris LLP

Tel: +1 (302) 657-4906
Fax: +1 (302) 657-4901

1201 North Market Street, Suite 501

Amneal Pharmaceuticals LLC Operating Company

Represented By

1 Attorneys Listed

Richard L. Renck

Duane Morris LLP

Tel: +1 (302) 657-4906
Fax: +1 (302) 657-4901

1201 North Market Street, Suite 501

Plaintiff

Teva Neuroscience, Inc. Operating Company

Represented By

2 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Teva Pharmaceutical Industries Ltd. Operating Company

Represented By

2 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Teva Pharmaceuticals USA, Inc. Operating Company

Represented By

2 Attorneys Listed

Karen Elizabeth Keller

Shaw Keller LLP

Tel: +1 (302) 298-0700

1105 North Market Street, 12th Floor, Wilmington, DE 19801

John W. Shaw

Shaw Keller LLP

Tel: +1 (302) 298-0701

I.M. Pei Building, 1105 North Market Street

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 25 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (25): πŸ‡¨πŸ‡¦ Canada CN πŸ‡ͺπŸ‡Ί Europe πŸ‡―πŸ‡΅ Japan KR πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US9155775
Process for manufacturing glatiramer acetate product
Filed: 2015-01-28
Issued: 2015-10-13
Active (8.2 yrs remaining)
Expires: 2035-01-28

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

11

Dispositive

0

Granted

1

Denied

0

Pending / Review

9

Motions by Category

Procedural / Extension Motion 7 Motion to Stay 2 Claim Construction / Markman Filing 2

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending
SO ORDERED - re (91 in 1:17-cv-00249-GMS, 110 in 1:16-cv-01267-GMS, 57 in 1:17-cv-00693-GMS, 116 in 1:17-cv-00597-GMS, 92 in 1:17-cv-00390-GMS, 40 in 1:17-cv-00...
Entry #β€” • 2017-08-15
Claim Construction / Markman Filing Pending / Under Review
CLAIM Construction Chart by Teva Neuroscience, Inc., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Yeda Research and Development Co., Ltd...
Entry #42 • 2017-08-09 Document →
Procedural / Extension Motion Pending / Under Review
MOTION for Leave to Appear Pro Hac Vice Patrick C. Gallagher Filing fee $ 150, receipt number 0207-9410159. by Amneal Pharmaceuticals Co. GmbH, Amneal Pharmaceu...
Entry #25 • 2017-03-30 Document →
Motion to Stay Granted
STIPULATION AND ORDER: THE PARTIES HEREBY STIPULATE AND AGREE, subject to the approval of the Court, as follows: 1. This case is STAYED for all purposes pending...
Entry #26 • 2017-03-29 Document →
Procedural / Extension Motion Pending / Under Review
MOTION for Leave to Appear Pro Hac Vice Anthony J. Fitzpatrick Filing fee $ 150, receipt number 0207-9394436. by Amneal Pharmaceuticals Co. GmbH, Amneal Pharmac...
Entry #23 • 2017-03-24 Document →
Procedural / Extension Motion Pending / Under Review
MOTION for Leave to Appear Pro Hac Vice Daryl L. Wiesen Filing fee $ 150, receipt number 0207-9339939. by Teva Neuroscience, Inc., Teva Pharmaceutical Industrie...
Entry #14 • 2017-03-03 Document →

Docket Entries

(56 total)
Pleading / Complaint

COMPLAINT against Amneal Pharmaceuticals Co. GmbH, Amneal Pharmaceuticals LLC filing fee $ 400, receipt number 0207-9235810 Was the Disclosure Statement on Civil Cover Sheet completed -YES,, filed by Teva Pharmaceuticals USA, Inc., Teva Neuroscience, Inc., Teva Pharmaceutical Industries Ltd.. (Attachments: # 1 Civil Cover Sheet, # 2 Proposed Summons for Amneal Pharmaceuticals LLC, # 3 Proposed Summons for Amneal Pharmaceuticals Co. GmbH, # 4 Exhibit A, # 5 AO120 Report on the Filing or Determination of an Action Regarding a Patent or Trademark) (Hashmall, David) [Transferred from New York Eastern on 7/21/2017.] (Entered: 01/25/2017)

Entry #1 • 2017-01-25
1

This attorney case opening filing has been checked for quality control. See the attachment for corrections that were made. (Davis, Kimberly) (Main Document 2 replaced on 1/27/2017) (Flanagan, Doreen). Modified on 1/27/2017 (Flanagan, Doreen). [Transferred from New York Eastern on 7/21/2017.] (Entered: 01/26/2017)

Entry #2 • 2017-01-26
1
Court Order

In accordance with Rule 73 of the Federal Rules of Civil Procedure and Local Rule 73.1, the parties are notified that if all parties consent a United States magistrate judge of this court is available to conduct all proceedings in this civil action including a (jury or nonjury) trial and to order the entry of a final judgment. Attached to the Notice is a blank copy of the consent form that should be filled out, signed and filed electronically only if all parties wish to consent. The form may also be accessed at the following link: http://www.uscourts.gov/uscourts/FormsAndFees/Forms/AO085.pdf. You may withhold your consent without adverse substantive consequences. Do NOT return or file the consent unless all parties have signed the consent. (Flanagan, Doreen) [Transferred from New York Eastern on 7/21/2017.] (Entered: 01/27/2017)

Entry #3 • 2017-01-27
1
Pleading / Complaint

Notice of Report on the filing of an action regarding a Patent. (Attachments: # 1 Complaint, # 2 Exhibit A) (Flanagan, Doreen) [Transferred from New York Eastern on 7/21/2017.] (Entered: 01/27/2017)

Entry #4 • 2017-01-27
1

Summons Issued as to Amneal Pharmaceuticals LLC. (Flanagan, Doreen) [Transferred from New York Eastern on 7/21/2017.] (Entered: 01/27/2017)

Entry #5 • 2017-01-27
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc